PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsFluorodopa f-18
Fluorodopa f 18
Fluorodopa F (fluorodopa f 18) is a small molecule pharmaceutical. Fluorodopa f 18 was first approved as Fluorodopa f18 on 2019-10-10.
Download report
Favorite
FDA Novel Drug Approvals 2019
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
fluorodopaNew Drug Application2021-01-15
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
FLUORODOPA F-18, FLUORODOPA F18, FEINSTEIN
2024-10-10NCE, W
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V09: Diagnostic radiopharmaceuticals
— V09I: Tumour detection radiopharmaceuticals
— V09IX: Other diagnostic radiopharmaceuticals for tumour detection in atc
— V09IX05: Fluorodopa (18f)
HCPCS
No data
Clinical
Clinical Trials
2319 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RecurrenceD012008————1——1
Multiple sclerosisD009103EFO_0003885G35——1——1
Chronic progressive multiple sclerosisD020528EFO_0003840———1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Alzheimer diseaseD000544EFO_0000249F0341——38
Triple negative breast neoplasmsD064726———1——12
Non-small-cell lung carcinomaD002289——11———1
Non-hodgkin lymphomaD008228—C85.9—1———1
Large b-cell lymphoma diffuseD016403—C83.3—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SchizophreniaD012559EFO_0000692F201————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cognitive dysfunctionD060825—G31.84————22
Pick disease of the brainD020774EFO_0003096G31.01————22
Healthy volunteers/patients———————11
DiseaseD004194EFO_0000408R69————11
DementiaD003704EFO_0003862F03————11
Frontotemporal dementiaD057180—G31.0————11
Progressive supranuclear palsyD013494EFO_0002512G23.1————11
NeoplasmsD009369—C80————11
CardiotoxicityD066126EFO_1001482—————11
Carotid artery diseasesD002340EFO_0003781—————11
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFluorodopa f 18
INNfluorodopa (18f)
Description
6-((18)F)fluoro-L-dopa is a 6-fluoro-L-dopa and a (18)F radiopharmaceutical.
Classification
Small molecule
Drug classdopamine receptor agonists
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
N[C@@H](Cc1cc(O)c(O)cc1[18F])C(=O)O
Identifiers
PDB—
CAS-ID92812-82-3
RxCUI—
ChEMBL IDCHEMBL3400972
ChEBI ID49166
PubChem CID56494
DrugBankDB13848
UNII ID2C598205QX (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,908 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
37 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use